Female-to-male transgender quality of life.
OBJECTIVE
We evaluated health-related quality of life in female-to-male (FTM) transgender individuals, using the Short-Form 36-Question Health Survey version 2 (SF-36v2).


METHODS
Using email, Internet bulletin boards, and postcards, we recruited individuals to an Internet site (http://www.transurvey.org), which contained a demographic survey and the SF36v2. We enrolled 446 FTM transgender and FTM transsexual participants, of which 384 were from the US.


RESULTS
Analysis of quality of life health concepts demonstrated statistically significant (p<0.01) diminished quality of life among the FTM transgender participants as compared to the US male and female population, particularly in regard to mental health. FTM transgender participants who received testosterone (67%) reported statistically significant higher quality of life scores (p<0.01) than those who had not received hormone therapy.


CONCLUSIONS
FTM transgender participants reported significantly reduced mental health-related quality of life and require additional focus to determine the cause of this distress. Providing this community with the hormonal care they request is associated with improved quality of life.
Newfield
Emily
E
School of Medicine, University of California, San Francisco, CA, USA. emily.newfield@gmail.com
Hart
Stacey
S
Dibble
Suzanne
S
Kohler
Lori
L
D000328:Adult; D000728:Androgens / Q000008:administration & dosage; D012734:Disorders of Sex Development; D005260:Female; D005783:Gender Identity; D006304:Health Status; D006306:Health Surveys; D006801:Humans; D008297:Male; D008875:Middle Aged; D011788:Quality of Life; D011795:Surveys and Questionnaires; D013739:Testosterone / Q000008:administration & dosage; D014189:Transsexualism / Q000523:psychology*
D000728:Androgens; D013739:Testosterone